Is It Really Illegal to Sell Your Placenta in 2026?

Selling your placenta is not explicitly illegal under federal law, but it exists in a tight legal gray zone that trips up most people who try. The question of whether it is illegal to sell your placenta does not have one clean national answer, and that ambiguity is exactly what causes so much confusion.

Federal law draws a hard line against profiting from human organs. But the placenta is not classified the same way an organ is, and that distinction matters.

On a related note, check out Is It Illegal to Get a Happy Ending? 2026 State Laws

State laws add another layer. Some states have specific rules about who owns your placenta and what can be done with it. Others are silent on the issue entirely.

This article breaks down federal law, state-by-state differences, FDA regulations, the commercial market, and what actually happens to people who try to sell.

Is It Illegal to Sell Your Placenta

Selling your placenta is not straightforwardly illegal at the federal level, but it is heavily restricted in ways that make a direct sale nearly impossible without running into legal problems. The placenta occupies an unusual legal category: it is human biological tissue, not an organ, which means the rules that apply to it are different from the rules covering hearts, kidneys, or livers.

The National Organ Transplant Act (NOTA), passed in 1984, prohibits the sale of human organs for transplantation. The placenta is not listed among those organs. That gap in the law creates a gray zone where selling placenta tissue is not outright banned by that specific statute.

However, that does not mean you can freely sell it. FDA regulations under 21 CFR Part 1271 govern human cells, tissues, and cellular and tissue-based products (HCT/Ps). Those rules impose requirements on collection, processing, and distribution that most individual sellers cannot meet.

State laws also vary. Some states classify placenta as hospital waste or hospital property by default. Others give the patient explicit rights over it. The legal picture depends heavily on where you give birth and what your hospital’s policies say.

Key legal facts at a glance:

• NOTA does not explicitly list placenta as a prohibited sale item
• FDA regulations apply to how placenta is processed and distributed commercially
• State laws determine ownership rights at the moment of birth
• Hospitals often have internal policies that override patient assumptions

Is It Legal to Sell Your Placenta

It is technically legal in the sense that there is no single federal law that says “selling a placenta is a crime.” But in practice, selling it for money runs into so many regulatory barriers that it rarely works out cleanly for an individual. The legal status depends on what the sale looks like and who is on the receiving end.

Selling placenta directly to a stranger, through Craigslist, or on an online marketplace is where things get complicated fast. Platforms themselves often remove these listings. More importantly, the buyer would need to use that tissue in some way, and any commercial use triggers FDA oversight.

The cleaner path some people take is working with licensed tissue banks or research companies that accept placentas through a formal donation process. Those companies may provide a gift card or nominal payment, but they frame it as “compensation for time and inconvenience,” not as payment for tissue. That distinction is legally meaningful.

Can You Sell Your Placenta for Money

You can receive money in connection with your placenta, but calling it a “sale” is where you enter risky legal territory. The functional difference between legal and illegal here comes down to what the payment is for.

Federal and state regulators look at whether the money is compensation for donating biological material (which can be acceptable) or payment for the tissue itself as a product (which is not). Think of it like plasma donation: you can get paid for your time and the process, but you cannot technically “sell” your blood.

Some tissue procurement companies do offer gift cards, ranging from small amounts to a few hundred dollars, in exchange for placenta donation agreements signed before birth. These arrangements are set up carefully to stay on the right side of FDA guidance.

Trying to negotiate your own price with a buyer, list it on an online marketplace, or ship it to someone without regulatory oversight is where individual sellers get into trouble. The payment itself is not the crime in most cases; the lack of proper licensing, handling procedures, and documentation is.

What “getting paid” can legally look like:

• A small gift card from a licensed tissue bank
• Reduced fees from a placenta encapsulation company (they charge for service, not tissue)
• Research participation payments from an IRB-approved study
• Nothing: most legal arrangements pay little to nothing to individual donors

Federal Law on Selling Human Placenta

The primary federal law people point to is the National Organ Transplant Act of 1984. NOTA makes it illegal to acquire, receive, or transfer any human organ for valuable consideration for use in human transplantation. The organs listed include kidneys, livers, hearts, lungs, pancreases, bone marrow, corneas, eyes, bones, skin, and more. Placenta is not on that list.

That absence is significant. Congress has not amended NOTA to include placenta. That means the federal criminal prohibition on organ sales does not directly apply to placenta the same way it applies to, say, a kidney.

The FDA steps in through a different channel. Under 21 CFR Part 1271, the FDA regulates HCT/Ps, which stands for human cells, tissues, and cellular and tissue-based products. Placenta falls into this category. Any establishment that recovers, processes, stores, labels, packages, or distributes HCT/Ps must register with the FDA and comply with current good tissue practice regulations.

An individual trying to sell their placenta without going through a registered establishment is, at minimum, operating outside FDA oversight. That creates civil and potentially criminal liability if the tissue ends up being used in a medical or commercial context.

Is It Illegal to Sell Body Parts in the US

Selling most human body parts in the US is a federal crime. NOTA created this framework in direct response to cases where individuals and brokers tried to profit from organ shortages during the transplant crisis of the 1980s. The law carries serious criminal penalties, including prison time.

The definition of “organ” under NOTA is broad enough to cover tissue in some interpretations. However, regulators and courts have not treated placenta the same way as organs like kidneys or hearts. Placenta is shed naturally after birth. It serves no ongoing function in the body. Those biological facts affect how the law treats it.

Selling blood plasma, eggs, and sperm is also a topic people often confuse with organ selling. Those are legal in the US because they are sold as services or through specific regulatory frameworks, not as organ sales. The placenta sits in a similar gray zone but without the same established commercial market or regulatory clarity.

Body parts: legal vs. illegal to sell in the US

Placenta Selling Laws by State

State laws create the most direct rules about what happens to your placenta after birth. While federal law provides the regulatory ceiling, states set the baseline for ownership, hospital policy requirements, and local restrictions on what patients can do with their placenta.

Most states do not have a specific statute that says “you may or may not sell your placenta.” Instead, they rely on hospital regulations, health department rules, and general tissue laws. A handful of states have addressed placenta rights in the context of allowing patients to take it home, which is a different question than selling it.

California, for example, allows patients to request their placenta for personal use, including consumption and encapsulation. The California Health and Safety Code addresses placenta as pathological waste that hospitals must release upon patient request. That does not mean you can sell it; it means you can take it.

New York hospitals must release the placenta to the patient if requested. Texas has similar policies rooted in patient rights over biological material. Florida does not have a specific statute but generally follows hospital-level policies.

Key Takeaway: No federal law bans placenta sales outright, but FDA regulations, state hospital policies, and the general legal framework around human tissue make direct sales extremely difficult and legally risky for most individuals.

States Where Selling Placenta Is Legal

No state has passed a law explicitly legalizing the sale of placenta by an individual. That matters because “legal” and “not explicitly banned” are two different things. In most states, the absence of a specific prohibition does not mean you have a clear legal right to sell.

The states with the most permissive frameworks around placenta access are those that have codified patient rights to receive it after birth. California leads here. Its health statutes treat placenta as pathological waste that belongs to the patient, not the hospital, if requested. But even there, selling it for cash is not addressed or sanctioned.

States without any placenta-specific law leave the question open. In those states, general laws on human tissue, property rights, and FDA compliance would govern. An individual in those states selling placenta to a private buyer might not face a specific state criminal charge, but they could still face FDA regulatory action if the tissue ends up in commercial use.

The safest states to work with licensed tissue banks or research programs are those with clear patient-first policies on biological material. Those states make it easier to navigate the donation-with-compensation pathway, which is the most legally defensible option available.

Who Owns Your Placenta After Birth

Legally, you own your placenta. Courts in the US have generally held that a person retains property rights over biological material that separates from their body. The placenta, as tissue generated and shed by the birthing person, is theirs to claim.

This principle comes from broader common law traditions around bodily autonomy and property rights. The legal concept of res sua, or “one’s own thing,” applies here. Your body produces it; it belongs to you.

The catch is that hospitals often treat placenta as biological or pathological waste by default. If you do not affirmatively request it, many hospitals will dispose of it according to their standard protocols for medical waste. That does not mean ownership transfers to the hospital; it means the hospital is acting as a de facto custodian in the absence of a patient claim.

Some hospitals have patients sign forms at admission that address what happens to biological materials. Reading those forms carefully matters. A signed agreement handing rights over to the hospital could complicate a later ownership claim.

What ownership means in practice:

This is also helpful — Is It Illegal to Fly Another Country’s Flag in America? 2026

• You can request your placenta at any hospital in most states
• The request usually needs to be made before or during delivery
• The hospital cannot sell it without your consent
• Your ownership does not automatically create a right to sell it commercially

Can Hospitals Keep Your Placenta

Hospitals can keep your placenta only if you do not request it or if you have signed documentation agreeing to let them handle it. If you say nothing, most hospitals will treat it as medical waste and dispose of it. That is the default in nearly every state.

Hospitals do profit from placentas in some cases. Academic medical centers and research hospitals often have arrangements with pharmaceutical companies or tissue banks. When a patient does not claim their placenta, the hospital may transfer it to these organizations, sometimes receiving payment or research credits in exchange.

This is legal because the hospital is operating as a licensed tissue procurement organization or working with one. They have FDA registration, proper handling protocols, and consent frameworks built into their admission paperwork. The patient signed a general consent form covering biological material use.

If you want to prevent the hospital from retaining or using your placenta, you need to make that request explicit, in writing, before delivery. A verbal request at the last minute may not be enough in a busy labor and delivery setting.

Is It Legal to Take Your Placenta Home

Taking your placenta home is legal in the majority of US states. Several states have enacted specific protections for this right. Others allow it under general patient rights frameworks. A handful of hospitals in states without clear laws have internal policies that try to restrict it, but those policies are often inconsistent with patient rights law.

Oregon passed a law in 2013 directly addressing this. HB 2612 requires hospitals to release the placenta to the patient upon request. California, Washington, and New York have similar frameworks either through statute or health department guidance.

Some hospitals require that you transport it in a specific type of container and sign a liability waiver before leaving with it. Those requirements are generally legal; they are about safety protocols, not blocking your right to take it.

If a hospital refuses your request without a specific legal basis, that refusal may be challengeable under state health law. Documenting your request in writing before your delivery date is the most practical protection.

Key Takeaway: You legally own your placenta in most states, and you can take it home in the majority of jurisdictions. Whether you can then sell it is a separate and more complicated legal question.

Placenta Donation vs Selling

Donating your placenta and selling it are legally distinct in ways that matter. Donation involves transferring your placenta to a licensed organization, like a tissue bank or research institution, without receiving payment specifically for the tissue. Selling means receiving compensation that is tied to the value of the tissue itself.

The difference is not just semantic. Federal guidance and FDA regulations permit donation-based models while prohibiting commercial tissue sales that circumvent the regulatory framework. Licensed tissue banks must meet strict requirements: FDA registration, donor screening, processing standards, and tracking systems.

When you donate, you often receive a gift card or small payment. That payment is classified as compensation for your time, travel, or inconvenience, not as the price of the tissue. Courts and regulators have accepted this framing, and it is the same model used for plasma donation and clinical trial participation.

The practical difference for someone giving birth is significant. Donation through a proper channel is legally clean and sometimes comes with modest compensation. Attempting to sell directly to an unknown buyer is where the legal exposure starts.

Donation vs. selling: key differences

FDA Regulations on Human Placenta

The FDA classifies placenta as a human cell, tissue, and cellular and tissue-based product (HCT/P) under 21 CFR Part 1271. This classification triggers a full regulatory framework that applies whenever placenta is recovered, processed, stored, or distributed for any use other than personal consumption by the person who birthed it.

Any company, hospital, or individual that wants to collect and distribute placenta tissue must register with the FDA as a tissue establishment. They must follow current good tissue practice (cGTP) regulations. They must screen donors for relevant communicable diseases. They must maintain records and submit to FDA inspection.

An individual who gives birth cannot register as a tissue establishment. That means any attempt to collect and ship placenta to a buyer for commercial use, medical application, or research falls outside what the FDA allows for unregistered individuals.

The FDA has also taken positions specifically on placenta encapsulation. In guidance documents, the agency has noted that encapsulated placenta products intended for consumption by someone other than the birth mother would be considered a human tissue product subject to regulation. Products intended for the birth mother’s own use, however, fall outside the HCT/P framework.

FDA framework summary for placenta:

• 21 CFR Part 1271 governs all commercial handling of placenta tissue
• FDA registration is required for any establishment distributing placenta
• Donor screening and cGTP rules must be followed
• Personal use by the birth mother is exempt from HCT/P rules
• Sale or transfer to others triggers full regulatory requirements

Penalties for Selling Human Tissue Illegally

The penalties for selling human tissue outside the legal framework range from civil fines to federal criminal charges, depending on what was sold, how, and with what intent. NOTA violations are federal felonies. A person convicted under NOTA faces up to five years in prison and fines up to $50,000 per violation.

For placenta specifically, the more likely enforcement pathway is FDA regulatory action rather than a NOTA criminal prosecution, since placenta is not on NOTA’s explicit organ list. The FDA can issue warning letters, mandate recalls, impose civil monetary penalties, and seek injunctions against individuals or businesses operating outside 21 CFR Part 1271.

State prosecutors could also get involved if a transaction violates state health codes governing biological materials or tissue handling. States like California and New York have their own tissue laws that carry independent penalties.

The risk of prosecution for a one-time individual seller trying to make a small amount of money is lower than for someone running a systematic operation. But “lower risk” is not “no risk,” especially if the tissue ends up being misused or if a federal agency decides to make an example.

Placenta Encapsulation Business Legality

Placenta encapsulation businesses operate in a legal gray zone that has not been fully resolved at the federal level. These businesses take the placenta, steam it, dehydrate it, and grind it into capsule form, usually for the birth mother’s own consumption. The business charges for the service, not for the placenta itself.

That service-based framing is what keeps most encapsulation businesses on the right side of the law. They are not selling placenta; they are selling a processing service. The FDA has not taken regulatory action against encapsulation businesses that serve only the birth mother.

The complication arises when a business makes health claims. The FDA prohibits unapproved health claims for products that function like drugs. If an encapsulation company markets its capsules as treating postpartum depression, increasing milk supply, or providing other medical benefits, it risks FDA enforcement as an unapproved drug product.

Key Takeaway: Placenta encapsulation businesses are generally legal when they charge for a service rather than for the tissue, and when they avoid making specific medical or health claims about their product.

State health departments have varied responses. Some states require food handler certifications for encapsulation practitioners. Others have no specific licensing requirement. A few have issued guidance suggesting encapsulators work from the client’s home rather than a commercial kitchen to sidestep food safety regulations that would otherwise apply.

Legal risks for encapsulation businesses:

Here's something related: Is It Illegal to Have a Crack in Your Windshield? 2026

• Making health or medical claims triggers FDA drug regulations
• Processing placenta from multiple clients in a commercial kitchen may trigger food safety laws
• Operating across state lines with a shipped product could implicate FDA interstate commerce rules
• No federal certification exists for placenta encapsulation practitioners

Selling Placenta to Pharmaceutical Companies

Selling your placenta directly to a pharmaceutical company is not a realistic option for most people in 2026. Pharmaceutical companies that use placental tissue do not source it through individual sellers. They work through licensed tissue procurement organizations, academic medical centers, or hospital systems that have the regulatory infrastructure to collect, screen, and process tissue properly.

Companies that produce products derived from placental tissue, including amniotic membrane grafts, biologic wound care products, and stem cell therapies, require tissue that has been handled under strict chain-of-custody protocols from the moment of delivery. That chain starts in a hospital operating room or delivery suite, not in someone’s home.

Some hospitals have agreements with pharmaceutical companies or affiliated tissue banks. When patients consent to tissue donation at admission, their placenta may go directly into that supply chain. The hospital or tissue bank may receive payment; the patient typically does not.

If you want to ensure your placenta goes to pharmaceutical research rather than being discarded, the most effective path is asking your hospital during prenatal visits whether they have a tissue donation program. Enrolling in that program before delivery is how the donation gets done properly.

How pharmaceutical companies legally source placenta:

• Through hospital-affiliated tissue procurement organizations
• Via licensed tissue banks with FDA registration
• Under informed consent protocols signed during hospital admission
• With full donor screening, testing, and chain-of-custody documentation

What Can Placenta Be Used for Commercially

Placental tissue has significant commercial value in medicine and biotech. Pharmaceutical and biomedical companies use it in multiple legitimate applications. That value is why the question of selling it comes up in the first place.

Amniotic membrane, which is part of the placental structure, is used in ophthalmology, wound care, and orthopedic surgery. Products made from amniotic tissue help with corneal repair, chronic wound healing, and soft tissue reconstruction. These are FDA-cleared medical devices or biologics.

Cord blood and placental blood contain hematopoietic stem cells that can be used in treating blood disorders, including leukemia and sickle cell disease. Cord blood banking, both public and private, is an established legal industry. Parents can donate cord blood to public banks at no cost or pay to store it privately.

Placental growth factors and proteins are also studied in research into fetal development, cancer biology, and regenerative medicine. Academic and commercial research institutions seek placental tissue samples for these studies through institutional review board (IRB) approved protocols.

Commercial uses of placental tissue:

• Amniotic membrane allografts for wound care and eye surgery
• Cord blood stem cell banking and transplantation
• Pharmaceutical research and biologic product development
• Cosmetic industry products (some face creams cite placental extracts)
• University and hospital-based medical research studies

How Much Can You Sell Your Placenta For

There is no established market price for placenta because there is no legal open market for it. The idea that you can sell your placenta for hundreds or thousands of dollars is largely a myth. The actual money that changes hands in legal arrangements is far more modest.

Licensed tissue banks that accept placenta donations may offer gift cards in the range of $25 to $75 for a qualified donation. Some research studies offer compensation in the range of $50 to $200 for tissue donation, framed as payment for participation, travel, or time. Those numbers reflect what researchers have been willing to pay in IRB-approved study protocols.

Placenta encapsulation services charge the birth mother anywhere from $150 to $400 for processing, but that money flows the other direction. You pay them for the service. The idea that you could flip that and receive thousands from a private buyer has no basis in the actual legal or commercial landscape.

Any listing you see online claiming to pay large sums for placentas is either fraudulent, operating outside FDA regulations, or both. The pharmaceutical and biomedical industries do not purchase individual placentas from the public at any price. They use institutional channels where costs are built into research and procurement budgets.

Realistic compensation ranges:

Can You Sell Placenta After Birth

Timing matters less than legal structure. Whether you try to sell it immediately after birth or weeks later, the same legal framework applies. You cannot legally sell placenta tissue to an unregistered buyer for commercial use, regardless of when the transaction happens.

After birth, the placenta can be refrigerated for a short period, typically 24 to 48 hours, before it degrades significantly. If you are planning to donate it to a tissue bank or research program, those organizations need to be notified before delivery so they can arrange proper collection and transport. Cold chain handling is required.

If you wait until after birth to start looking for a buyer, you have likely missed the practical window for tissue banks and research programs. Fresh placental tissue has a narrow window of viability for most research and medical uses. Trying to negotiate a private sale in that window is both legally risky and logistically unlikely to succeed.

The clearest and most legally defensible path remains the same regardless of timing: arrange a formal donation with a licensed organization before your delivery date, understand what compensation (if any) is offered, and have everything documented in writing before you give birth.

Key Takeaway: Selling placenta after birth carries the same legal restrictions as any other time. The tissue has a short viability window, and trying to arrange an unregulated private sale in that narrow period is both impractical and legally inadvisable.

Frequently Asked Questions

Is it illegal to sell your placenta in the United States?

There is no single federal law that makes selling a placenta an automatic crime, but doing it outside FDA-regulated channels is legally risky.
The National Organ Transplant Act does not list placenta among prohibited organs.
However, FDA regulations under 21 CFR Part 1271 govern any commercial distribution of human tissue, including placenta.
An individual selling placenta to an unregistered buyer is operating outside that framework, which creates both civil and potential criminal exposure.

Who legally owns your placenta after you give birth?

You own your placenta. Courts and legal tradition in the US recognize that biological material separated from your body belongs to you.
If you do not claim it, hospitals treat it as medical waste and may transfer it to tissue banks under existing consent agreements.
Asserting your rights means making a formal written request before or during delivery.
Signing hospital admission forms without reading them could affect your practical ability to claim it.

Can you get paid for donating your placenta to research?

Yes, in some cases. IRB-approved research studies may offer compensation ranging from $50 to $200 for placenta donation.
Licensed tissue banks sometimes provide gift cards of $25 to $75.
That compensation is always classified as payment for time and inconvenience, not payment for the tissue itself.
The distinction keeps the arrangement compliant with federal and FDA guidelines.

What happens if you try to sell your placenta online?

Most platform listings get removed because marketplaces prohibit the sale of human body parts or tissue.
If the sale does go through and the buyer uses the tissue commercially or medically, FDA regulations are triggered.
The seller could face regulatory scrutiny if they cannot document proper handling, donor screening, or any of the other requirements for tissue distribution.
The bigger risk is the buyer’s use of the tissue, not just the act of listing it.

Is placenta encapsulation legal in all states?

Placenta encapsulation for the birth mother’s own personal use is legal in all 50 states.
No state has passed a law banning it outright.
However, businesses that make health claims about encapsulated placenta products may face FDA scrutiny.
Some states have food safety or health department requirements that affect how encapsulation businesses operate, but the practice itself is not prohibited.

State laws, federal regulations, and FDA rules create a framework that makes outright placenta sales impractical and legally risky for most individuals. The gray zones exist, but they are narrow.

Understanding where the law draws the line protects you from acting on assumptions that could lead to real legal consequences. Keep this article handy before any delivery date if this topic applies to you.

This may also interest you — Is It Illegal to Walk Around Without ID? 2026 Laws